Aquestive Therapeutics, Inc. AQST Deferred Tax Assets - Tax Credit Carryforwards
Deferred Tax Assets - Tax Credit Carryforwards at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxCreditCarryforwards.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards?
- Aquestive Therapeutics, Inc. (AQST) reported deferred tax assets - tax credit carryforwards of $7.53M in Q4 2025.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s deferred tax assets - tax credit carryforwards has grown at a 25.2% compound annual growth rate (CAGR), from $4.81M to $7.53M.